The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
THE IL-4 RECEPTOR: Signaling Mechanisms and Biologic Functions
Abstract
Interleukin-4 is a multifunctional cytokine that plays a critical role in the regulation of immune responses. Its effects depend upon binding to and signaling through a receptor complex consisting of the IL-4R alpha chain and the common gamma chain (gamma c), resulting in a series of phosphorylation events mediated by receptor-associated kinases. In turn, these cause the recruitment of mediators of cell growth, of resistance to apoptosis, and of gene activation and differentiation. Here we describe our current understanding of the organization of the IL-4 receptor, of the signaling pathways that are induced as a result of receptor occupancy, and of the various mechanisms through which receptor function is modulated. We particularly emphasize the modular nature of the receptor and the specialization of different receptor regions for distinct functions, most notably the independent regulation of cell growth and gene activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“previous studies have shown that phosphorylation of STAT6 is a key step downstream in the IL-4 cascade that leads to Arg1 expression (49–51).”
From Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions (2020) · cites this paper as [50]
Citations
Cites
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
SH2 domains recognize specific phosphopeptide sequences
Songyang, Z. (1993) · Cell · doi:10.1016/0092-8674(93)90404-e · Cited by 2,620
Protein modules and signalling networks
Pawson, T. (1995) · Nature · doi:10.1038/373573a0 · Cited by 2,420
Human Growth Hormone and Extracellular Domain of Its Receptor: Crystal Structure of the Complex
de Vos, A. M., Ultsch, M. H., & Kossiakoff, A. A. (1992) · Science · doi:10.1126/science.1549776 · Cited by 2,237
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
Proteins regulating Ras and its relatives
Boguski, M. S., & McCormick, F. P. (1993) · Nature · doi:10.1038/366643a0 · Cited by 1,905
PI3K: Downstream AKTion Blocks Apoptosis
Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81883-8 · Cited by 1,665
Stat6 Is Required for Mediating Responses to IL-4 and for the Development of Th2 Cells
Kaplan, M. H., Schindler, U., Smiley, S. T., & Grusby, M. J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80439-2 · Cited by 1,629
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
Cited by
Sorted by citations
Items 701–800 of 1,002
Effects of IL-13 on airway responses in the guinea pig
Morse, B. W., Sypek, J. P., Donaldson, D. D., Haley, K. J., & Lilly, C. M. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00296.2001 · Cited by 32
“In addition to the IL-4 avid form of the heterodimeric receptor (IL-4 receptor -chain/common -chain), the IL-4 receptor -chain can combine with IL-13 receptor 1 and efficiently bind IL-13 (9, 12, 24); this realization in murine biology led to speculation that IL-13 was the mediator responsible for allergen-induced pul…”
BackgroundTuberculosis Due to High-Dose Challenge in Partially Immune Individuals: A Problem for Vaccination?
Rook, G. A. W., Hernández‐Pando, R., & Zumla, A. I. (2009) · The Journal of Infectious Diseases · doi:10.1086/596654 · Cited by 32
“Similarly, IL-4, IL-13, and TGF- will tend to deviate the recruitment of T cells away from Th1 and cytotoxic T cells and toward Th2 and regulatory T cells [15, 16, 21].”
BackgroundInfluentialGiallourakis, C. C., Kashiwada, M., Pan, P., Danial, N. N., Jiang, H., Cambier, J. C., Coggeshall, K. M., & Rothman, P. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002853200 · Cited by 32
Mearns, H., Horsnell, W. G. C., Hoving, J. C., Dewals, B. G., Cutler, A. J., Kirstein, F., Myburgh, E., Arendse, B., & Brombacher, F. (2008) · Infection and Immunity · doi:10.1128/iai.00210-08 · Cited by 31
“IL-4R signaling results in activation and upregulation of the transcription factors STAT-6 and GATA-3, which stabilize the TH2 program in polarized CD4 T cells (3, 27).”
BackgroundGuo, B., & Rothstein, T. L. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203211 · Cited by 33
“IL-4–induced upregulation of Iga and Igb expression requires STAT6 Upon binding of IL-4 to its receptor, two signaling pathways are activated: one is mediated by STAT6; the other is mediated by insulin receptor substrate 2 (IRS-2) (36).”
BackgroundInfluentialDasgupta, P., Dorsey, N., Li, J., Qi, X., Smith, E., Yamaji-Kegan, K., & Keegan, A. D. (2016) · Science Signaling · doi:10.1126/scisignal.aad6724 · Cited by 31
“A. E. Kelly-Welch, H. Y. Wang, L.-M. Wang, J. H. Pierce, G. Jay, F. Finkelman, A. D. Keegan, Transgenic expression of insulin receptor substrate 2 in murine B cells alters the cell density-dependence of IgE production in vitro and enhances IgE production in vivo.”
BackgroundInfluentialCytokines and Inflammatory Response in the Fetus and Neonate
Srinivasan, L., Harris, M. C., & Kilpatrick, L. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-35214-7.00128-1 · Cited by 31
Targeting IL-13 as a Host-Directed Therapy Against Ulcerative Colitis
Hoving, J. C. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00395 · Cited by 31
“The signal transducer and activator of transcription 6 (STAT6) is recruited to the phosphorylated IL-4Rα where it also becomes phosphorylated by JAKs (Nelms et al., 1999).”
BackgroundInfluentialCytokines profile in patients with acute and chronic hepatitis B infection
Ribeiro, C. R. D. A., Beghini, D. G., Salvio, A. L., Martinelli, K. G., Mello, V. M., de Almeida, N. A. A., Lewis‐Ximenez, L. L., & de Paula, V. S. (2021) · Microbiology and Immunology · doi:10.1111/1348-0421.12947 · Cited by 31
“High doses of IFN are capable of triggering noncytolytic elimination of cccDNA from infected primary human hepatocytes or HepaRG cells.44 Some studies have shown that viral replication often results in rapid production of IFN‐γ by the infected cell.45 Robust activation of IFN‐γ production by innate and adaptive immune…”
BackgroundInfluentialInoue, Y., Otsuka, T., Niiro, H., Nagano, S., Arinobu, Y., Ogami, E., Akahoshi, M., Miyake, K., Ninomiya, I., Shimizu, S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2147 · Cited by 31
“STAT3 and STAT6 play a crucial role in the signaling pathways for IL-10 and IL-4, respectively (46, 47).”
BackgroundDev, S., Mizuguchi, H., Das, A. K., Maeyama, K., Horinaga, S., Kato, S., Tamada, M., Hattori, M., Umehara, H., & Fukui, H. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09003fp · Cited by 31
Xu, S. B., Liu, X. H., Li, B. H., Zhang, Y., Yuan, J., Yuan, Q., Li, P. D., Yang, X. Z., Li, F., & Zhang, W. J. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0627-z · Cited by 31
“Furthermore, the upregulation of gene expression after demethylation is also conWrmable at protein level at least for SHP-1 whose antibody was available (Fig. 5c, d). It is conceivable that, because of insuYcient levels of SOCS-1 and SHP-1, Stat6 may remain highly active in cells which would show overperformed Stat6-r…”
BackgroundInfluentialSasaki, K., Zhao, X., Pardee, A. D., Ueda, R., Fujita, M., Sehra, S., Kaplan, M. H., Kane, L., Okada, H., & Storkus, W. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.104 · Cited by 32
“IL-4 is known to activate two major signaling cascades: the IRSPI3K pathway that promotes the growth of target lymphocytes and the Jak-Stat6 pathway that induces the expression of IL-4-responsive genes (3, 4).”
BackgroundFunctional epitope of common γ chain for interleukin‐4 binding
Zhang, J.-L., Buehner, M., & Sebald, W. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02796.x · Cited by 31
Guo, B., & Rothstein, T. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5375 · Cited by 31
Immunotoxin Therapy for CNS Tumor
Rustamzadeh, E., Low, W. C., Vallera, D. A., & Hall, W. A. (2003) · Journal of Neuro-Oncology · doi:10.1007/bf02700025 · Cited by 31
Crepaldi, L., Silveri, L., Calzetti, F., Pinardi, C., & Cassatella, M. A. (2002) · International Immunology · doi:10.1093/intimm/dxf079 · Cited by 31
“IL-4-, as well as LPS-, dependent responses are mediated through various signaling pathways, including activation of phosphatidylinositol-3¢ kinase (PI3 kinase), p38 mitogen-activated protein kinase (p38 MAPK) and p42/44 extracellular signal-regulated protein kinase (ERK) MAPK, and serine/ threonine protein kinases (…”
BackgroundSTAT6 specific shRNA inhibits proliferation and induces apoptosis in colon cancer HT-29 cells
Zhang, M., Zhou, Y., Xie, C., Zhou, F., Chen, Y., Han, G., & Zhang, W. J. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.11.020 · Cited by 32
Florholmen, G., Andersson, K. B., Yndestad, A., Austbø, B., Henriksen, U. L., & Christensen, G. (2004) · Acta Physiologica Scandinavica · doi:10.1046/j.0001-6772.2003.01245.x · Cited by 30
Choi, D. W., Jung, S. Y., Shon, D., & Shin, H. S. (2020) · Molecules · doi:10.3390/molecules25092186 · Cited by 30
Pharmacodynamics of Janus kinase inhibitors for the treatment of atopic dermatitis
Calabrese, L., Chiricozzi, A., SIMONE, C. D., Fossati, B., D'Amore, A., & Peris, K. (2022) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2022.2099835 · Cited by 30
Design of cell-type-specific hyperstable IL-4 mimetics via modular de novo scaffolds
Yang, H., Ulge, U. Y., Quijano‐Rubio, A., Bernstein, Z. J., Maestas, D. R., Chun, J.-H., Wang, W., Lin, J., Jude, K. M., Singh, S., et al. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01313-6 · Cited by 31
“The type I complex is typically expressed on hematopoietic cells, whereas the type II complex is predominantly expressed on non-hematopoietic cells 4–6 .”
Critical YxKxHxxxRP Motif in the C-Terminal Region of GATA3 for Its DNA Binding and Function
Shinnakasu, R., Yamashita, M., Shinoda, K., Endo, Y., Hosokawa, H., Hasegawa, A., Ikemizu, S., & Nakayama, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5801 · Cited by 30
Grahnert, A., Richter, T., Piehler, D., Eschke, M., Schulze, B., Müller, U., Protschka, M., Köhler, G., Sabat, R., Brombacher, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087341 · Cited by 30
“Moreover, C. neoformans can cause an allergic bronchopulmonary mycosis characterized by production of Th2 cytokines (e.g. interleukin (IL)-4, IL-5, and IL-13), elevated levels of serum IgE, recruitment of eosinophils, and alternative activation of macrophages [5–8].”
BackgroundSaini, M. K., Vaish, V., & Sanyal, S. N. (2012) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3283584932 · Cited by 30
“IL-4 has been shown to be an anti-inflammatory cytokine involved in various immune responses with pleiotropic functions (Nelms et al., 1999).”
BackgroundEffect of IL-13 receptor α2 levels on the biological activity of IL-13 variant R110Q
Andrews, A.-L., Bucchieri, F., Arima, K., Izuhara, K., Holgate, S. T., Davies, D. E., & Holloway, J. W. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.04.026 · Cited by 30
Cândido, E. B., Silva, L. M., Teixeira‐Carvalho, A., Lamaita, R. M., Filho, R. M. P., Cota, B. D. C. V., & Filho, A. L. D. S. (2012) · Reproductive Sciences · doi:10.1177/1933719112466299 · Cited by 30
“Optimal cytoreduction occurred in 12 patients with stages I/II.”
BackgroundInfluentialExpression of IL-4/IL-13 receptors in differentiating human airway epithelial cells
White, S. R., Martin, L. D., Stern, R. K., Laxman, B., & Marroquin, B. A. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00422.2009 · Cited by 30
“IL-4 and IL-13 have overlapping but not identical effector profiles likely due to shared subunits in their receptor complexes (43).”
BackgroundSaeftel, M., Krueger, A., Arriens, S., Heussler, V. T., Rácz, P., Fleischer, B., Brombacher, F., & Hoerauf, A. M. (2003) · Infection and Immunity · doi:10.1128/iai.72.1.322-331.2004 · Cited by 30
“Indeed, IL-4 has many overlapping functions with IL-13 (5, 58), since both cytokines use the IL-4 receptor (IL-4r) chain, with IL-4 able to signal via the type 1 IL-4r, consisting of IL-4r and - chains or the type 2 IL-4r, consisting of the IL-4r and IL-13r chains (21, 34 ).”
BackgroundAcute inflammation primes myeloid effector cells for anti-inflammatory STAT6 signaling
Wermeling, F., Anthony, R. M., Brombacher, F., & Ravetch, J. V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312525110 · Cited by 29
“IL-4Rα is expressed by many cells, including both hematopoietic and nonhematopoietic cell populations (20).”
BackgroundEffect of TH2 cytokines and interferon gamma on beat frequency of human respiratory cilia
Große-Onnebrink, J., Werner, C., Loges, N. T., Hörmann, K., Blum, A., Schmidt, R., Olbrich, H., & Omran, H. (2016) · Pediatric Research · doi:10.1038/pr.2016.8 · Cited by 29
Connections between Immune-Derived Mediators and Sensory Nerves for Itch Sensation
Toyama, S., Tominaga, M., & Takamori, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212365 · Cited by 33
“IL-4-evoked mouse DRG neurons respond to calcium, and deletion of IL-4Ra on sensory neurons was found to disrupt scratching behavior in a mouse model of AD.”
BackgroundInfluentialZhao, H., Li, W., Lu, Z., Sheng, Z.-Y., & Yao, Y.-M. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0119 · Cited by 29
Determination of interleukin-4-responsive region in the human cytochrome P450 2E1 gene promoter
Abdel‐Razzak, Z., Garlatti, M., Aggerbeck, Μ., & Barouki, R. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.06.003 · Cited by 29
Clinical Studies with Targeted Toxins in Malignant Glioma
Rainov, N. G., & Söling, A. (2006) · Reviews on Recent Clinical Trials · doi:10.2174/157488706776876454 · Cited by 29
“IL-4 is a pleiotropic cytokine composed of 4 a -helices, which is primarily produced by Th2-type T lymphocytes [22, 23].”
BackgroundKaminski, A., Welters, H. J., Kaminski, E. R., & Morgan, N. G. (2009) · Bioscience Reports · doi:10.1042/bsr20090021 · Cited by 29
Leeto, M., Herbert, D. R., Marillier, R. G., Schwegmann, A., Fick, L., & Brombacher, F. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060346 · Cited by 29
“8,26 Such type 2 effector functions serve a host protective role against intestinal helminth infection 14 but also damages the body’s own tissues in various types of allergic disease.”
BackgroundInterleukin-4 elicits apoptosis of developing mast cells via a Stat6-dependent mitochondrial pathway
Bailey, D. P., Kashyap, M., Mirmonsef, P., Bouton, L. A., Domen, J., Zhu, J., Dessypris, E. N., & Ryan, J. J. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2003.10.011 · Cited by 29
Dewals, B. G., Hoving, J. C., Leeto, M., Marillier, R. G., Govender, U., Cutler, A. J., Horsnell, W. G. C., & Brombacher, F. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090137 · Cited by 29
Hiroi, M., Sakaeda, Y., Yamaguchi, H., & Ohmori, Y. (2013) · Mediators of Inflammation · doi:10.1155/2013/369693 · Cited by 30
Iseki, M., Omori‐Miyake, M., Xu, W., Sun, X., Takaki, S., Rawlings, D. J., & Ziegler, S. F. (2012) · International Immunology · doi:10.1093/intimm/dxr113 · Cited by 29
Singh, N. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0461-2 · Cited by 29
“IL-4 signal transduction by expression of GATA binding protein-3 (GATA3) polarizes the differentiation of Th0 to Th2 cells that produce antiinflammatory and immunosuppressive cytokines [14, 15].”
BackgroundDelayed allogeneic skin graft rejection in CD26-deficient mice
Zhao, X., Zhang, K., Daniel, P. T., Wisbrun, N., Fuchs, H., & Fan, H. (2018) · Cellular and Molecular Immunology · doi:10.1038/s41423-018-0009-z · Cited by 30
IL-4-stimulated NF-κB activity is required for Stat6 DNA binding
Thieu, V. T., Nguyen, E., McCarthy, B. P., Bruns, H. A., Kapur, R., Chang, C., & Kaplan, M. H. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1106707 · Cited by 31
“IL-4 stimulates several intracellular signaling pathways including the recruitment of Stat6 to the IL-4R , where it is phosphorylated on tyrosine 641 by Jak kinases [1, 3].”
BackgroundProtein Phosphatase 2A (PP2A) Regulates Interleukin-4-mediated STAT6 Signaling
Woetmann, A., Brockdorff, J. L., Lovato, P., Nielsen, M., Leick, V., Rieneck, K., Svejgaard, A., Geisler, C., & Ødum, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210196200 · Cited by 29
Robaee, A. A. A., Alzolibani, A. A., Shobaili, H. A. A., & Settin, A. (2012) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2012.349 · Cited by 28
He, L., Peng, Y., Liu, H., Yin, W., Chen, X., Peng, X., Shao, J., Liu, Y., & Liu, F. (2013) · American Journal of Nephrology · doi:10.1159/000355393 · Cited by 28
Immunopathology and Immunogenetics of Allergic Bronchopulmonary Aspergillosis
Knutsen, A. P. (2011) · Journal of Allergy · doi:10.1155/2011/785983 · Cited by 28
“IL-4 receptor type II, also known as the IL13 receptor, is formed by the association of IL-4RA with the IL-13RA subunits and is located on immune cells, bronchial epithelium, and vascular endothelium.”
BackgroundRetractedSay, Y.-H. (2017) · Journal of PHYSIOLOGICAL ANTHROPOLOGY · doi:10.1186/s40101-017-0142-x · Cited by 29
Schubart, C., Krljanac, B., Otte, M., Symowski, C., Martini, E., Günther, C., Becker, C., Daniel, C., & Voehringer, D. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0107-3 · Cited by 25
Interleukin-4 Promotes Myogenesis and Boosts Myocyte Insulin Efficacy
Chang, Y.-H., Tsai, J., Chen, T.-L., Ho, K.-T., Cheng, H. K., Hsiao, C., & Shiau, M. (2019) · Mediators of Inflammation · doi:10.1155/2019/4182015 · Cited by 28
“Anti-inflammatory interleukin-4 (IL-4) executes pleiotropic immune-regulatory functions [9].”
Pelaia, C., Pelaia, G., Crimi, C., Maglio, A., Armentaro, G., Calabrese, C., Sciacqua, A., Gallelli, L., & Vatrella, A. (2022) · Vaccines · doi:10.3390/vaccines10060974 · Cited by 30
“IL-4 specifically interacts with the α-subunit of its receptor (IL-4Rα), which recruits the γC chain, thus leading to the assembly of the dimeric type I receptor (IL-4Rα/γC) [61].”
BackgroundPolymorphisms and haplotype analysis of IL-4Rα Q576R and I75V in patients with penicillin allergy
Huang, C., Yang, J., Qiao, H., & Jia, L.-J. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0659-y · Cited by 28
“Type II IL-4R complexes consist of IL-4Rα and the interleukin-13 receptor α1 chain (IL-13Rα1), binding IL-4 and IL-13, and are present on both hematopoietic and nonhematopoietic cells [ 9 ].”
BackgroundPolymorphisms in the IL-13 and IL-4 receptor alpha genes and allergic rhinitis
Kim, J. J., Min, J. Y., & Lee, J.-H. (2006) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-006-0204-x · Cited by 28
“The binding of IL-4 to its receptor activates several signaling molecules that can translocate to the nucleus and bind to speciWc DNA sequences in the promoter regions of target genes (e.g., I, CD23, and MHC II) [ 8 ].”
BackgroundA Critical Role of SHP-1 in Regulation of Type 2 Inflammation in the Lung
Oh, S. Y., Zheng, T., Kim, Y., Cohn, L. E., Homer, R., McKenzie, A. N. J., & Zhu, Z. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0225oc · Cited by 28
“Some of the molecules involved in the negative regulation of IL-4Ra signaling may include suppressor of cytokine signaling, B-cell lymphoma (BCL)-6, SH2 domaincontaining inositol 5-phosphatase (SHIP)-1, and Src homology 2 domain–containing protein tyrosine phosphatase (SHP)-1 (1, 2).”
BackgroundAlternatively spliced variants of interleukin-4 promote inflammation differentially
Luzina, I. G., Lockatell, V., Todd, N. W., Highsmith, K., Keegan, A. D., Hasday, J. D., & Atamas, S. P. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0510271 · Cited by 28
“It shares sequence homology, receptor chains, and some functional effects with IL-13 [1].”
BackgroundInfluentialTrim32 Deficiency Enhances Th2 Immunity and Predisposes to Features of Atopic Dermatitis
Liu, Y., Wang, Z., Torre, R. D. L., Barling, A. N., Tsujikawa, T., Hornick, N. I., Hanifin, J. M., Simpson, E. L., Wang, Y., Swanzey, E., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.09.020 · Cited by 29
“The expression of IL-17A and CCL20 is mediated through Stat3 (Hau et al., 2014; Li et al., 2015; Mack et al., 2012), whereas the expression of IL-4 and IL-5 is mediated through Stat6 (Chan et al., 2001; Nelms et al., 1999).”
InfluentialFungal immunomodulatory protein-fve could modulate airway remodel through by affect IL17 cytokine
Lee, Y.-T., Wu, C.-T., Sun, H., Ko, J., & Lue, K.-H. (2017) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2017.06.008 · Cited by 28
Interleukin-4 and Interleukin-10 Gene Polymorphisms in Patients with Inflammatory Bowel Disease
Daryani, N. E., Saghazadeh, A., Moossavi, S., Sadr, M., Shahkarami, S., Soltani, S., Farhadi, E., & Rezaei, N. (2017) · Immunological Investigations · doi:10.1080/08820139.2017.1360343 · Cited by 28
“Example range from cytokine production, immunoglobulin isotype switching, inflammation to tissue adhesion (Nelms et al., 1999).”
BackgroundArndt, L., Dokas, J., Gericke, M. T., Kutzner, C. E., Müller, S., Jeromin, F., Thiery, J., & Burkhardt, R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000703 · Cited by 28
“Currently, it is not clear how Trib1 controls the abundance of JAK1 and JAK3 in macrophages.”
BackgroundInfluentialCCL2/MCP-1 signaling drives extracellular matrix turnover by diverse macrophage subsets
Jürgensen, H. J., Silva, L. M., Krigslund, O., van Putten, S., Madsen, D. H., Behrendt, N., Engelholm, L. H., & Bugge, T. H. (2019) · Matrix Biology Plus · doi:10.1016/j.mbplus.2019.03.002 · Cited by 28
“The latter observation is unexpected in light of the, at least partially shared, receptor subsets of IL-4 and IL-13 [57,58], and highlights the functional differences of the two wound healing-associated cytokines.”
Interleukins and STAT Signaling
Haque, S. J., & Sharma, P. (2006) · Vitamins and hormones · doi:10.1016/s0083-6729(06)74007-9 · Cited by 28
Expression and Targeting of Interleukin-4 Receptor for Primary and Advanced Ovarian Cancer Therapy
Kioi, M., Takahashi, S., Kawakami, M., Kawakami, K., Kreitman, R. J., & Puri, R. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1043 · Cited by 28
“Interleukin-4 (IL-4) is an important Th2-derived cytokine, which is involved in mediating numerous antitumor immune-modulating activities (5).”
BackgroundNishikubo, K., Murata, Y., Tamaki, S., Sugama, K., Imanaka‐Yoshida, K., Yuda, N., Kai, M., Takamura, S., Sebald, W., Adachi, Y., et al. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302131 · Cited by 28
Wang, C., Tay, S. S., Tran, G. T., Hodgkinson, S. J., Allen, R. D. M., Hall, B. M., McCaughan, G. W., Sharland, A. F., & Bishop, G. A. (2009) · Transplant Immunology · doi:10.1016/j.trim.2009.11.005 · Cited by 28
“IL-4 plays a central role in humoral and cell-mediated immunity where it promotes B cell activation and immunoglobulin classswitching, as well as T cell survival and differentiation (reviewed in [1]).”
BackgroundWebb, D. C., Matthaei, K. I., Cai, Y., McKenzie, A. N. J., & Foster, P. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.1092 · Cited by 28
“(11, 12) and in isotype switching of B cell Ab production to IgE”
BackgroundDorsey, N., Chapoval, S. P., Smith, E., Skupsky, J., Scott, D. W., & Keegan, A. D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300486 · Cited by 27
IL-4-dependent CD86 expression requires JAK/STAT6 activation and is negatively regulated by PKCδ
Deszo, E. L., Brake, D. K., Kelley, K. W., & Freund, G. G. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(03)00137-2 · Cited by 27
Hu, Y., He, K., & Wang, X. (2015) · Journal of Immunotoxicology · doi:10.3109/1547691x.2015.1017624 · Cited by 27
“IL-4 aids in antigen-stimulated polarization of naive TH cells into TH2 effector cells and also helps to propagate TH2 responses by binding its receptor (IL-4R ) and activating signal transducer and activator of transcription (STAT)-6 signaling pathways (Nelms et al., 1999; Shimoda et al., 1996).”
BackgroundQiu, L., Ni, J., Cen, H., Wen, P., Zhang, M., Liang, Y., Pan, H., Mao, C., & Ye, D. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12435 · Cited by 36
On the Role IL-4/IL-13 Heteroreceptor Plays in Regulation of Type 1 Diabetes
Ukah, T., Cattin-Roy, A. N., Chen, W., Miller, M. M., Barik, S., & Zaghouani, H. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700410 · Cited by 27
“the HR on other cell types (10) to drive anti-inflammatory function against Th1 cells.”
BackgroundLewis, E. D., Ren, Z., DeFuria, J., Obin, M. S., Meydani, S. N., & Wu, D. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114518001034 · Cited by 28
Interleukin 4 induces the expression of inducible nitric oxide synthase in eosinophils
Paoliello-Paschoalato, A. B., Oliveira, S. H. P., & Cunha, F. Q. (2005) · Cytokine · doi:10.1016/j.cyto.2005.01.001 · Cited by 27
Zhou, X., Trudeau, J. B., Schoonover, K. J., Lundin, J. I., Barnes, S. M., Cundall, M. J., & Wenzel, S. E. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00035.2004 · Cited by 27
“In addition to STAT-6, the IL-4R molecule has been reported to signal through an IRS-PI3K-Akt pathway (3, 24).”
Becker, Y. (2004) · Virus genes · doi:10.1023/b:viru.0000025778.56507.61 · Cited by 27
Kruse, S., Braun, S. L., & Deichmann, K. A. (2002) · Respiratory Research · doi:10.1186/rr174 · Cited by 27
“A variety of inhibitors of the IL-4/IL-13 pathway have been reported, such as SOCS-1 (also known as SSI-1) [21]; however, this inhibitor was suggested to prevent activation of STAT and, for example, act on Jak proteins [37].”
Biological Functions of Interleukin-21 and Its Role in Inflammation
Pelletier, M., & Girard, D. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.275 · Cited by 28
“immune responses[15].”
Fes Mediates the IL-4 Activation of Insulin Receptor Substrate-2 and Cellular Proliferation
Jiang, H., Foltenyi, K., Kashiwada, M., Donahue, L., Vuong, B. Q., Hehn, B. T., & Rothman, P. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2627 · Cited by 27
“PtdIns(3,4,5)P3, an enzymatic product of PI3-kinase, is thought to activate two different protein kinases, Akt/PKB and p70S6K (36, 37), lthough the mechanisms by which PtdIns(3,4,5)P3 regulates these two kinases appear to differ (38).”
BackgroundJanus kinase-3 dependent inflammatory responses in allergic asthma
Malaviya, R., Laskin, D. L., & Malaviya, R. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.04.014 · Cited by 27
“Binding of IL-4 to its cognate receptor on B cells triggers tyrosine phosphorylation of JAK-1 and JAK-3 [85, 86].”
BackgroundAdhami, N., Chen, Y., & Martins‐Green, M. M. (2017) · Clinical Science · doi:10.1042/cs20171053 · Cited by 26
Lee, H. K., Koh, S., Lo, D. C., & Marchuk, D. A. (2018) · FEBS Journal · doi:10.1111/febs.14498 · Cited by 26
Cytokines and cytokine receptors
O’Shea, J. J., Gadina, M., & Siegel, R. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7234-3691-1.00033-7 · Cited by 27
Andrews, A.-L., Nordgren, I. K., Campbell-Harding, G., Holloway, J. W., Holgate, S. T., Davies, D. E., & Tavassoli, A. (2013) · Molecular BioSystems · doi:10.1039/c3mb70298g · Cited by 26
Barnaba, V. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.003 · Cited by 26
“) with protective responses against extracelllular pathogens or harmful responses in the case of allergic reactions [93].”
BackgroundRiou, C., Dumont, A. R., Yassine‐Diab, B., Haddad, E. K., & Sékaly, R. (2006) · International Immunology · doi:10.1093/intimm/dxl019 · Cited by 22
“which IL-4 promotes the expression of Bcl-2 is unclear but most probably involves the activation, through the IL-4R signaling pathway, of Akt/PKB, which is known to regulate the expression of Bcl-2 family proteins including Bcl-2 ( 7 ).”
BackgroundInfluentialSpatial regulation of IL-4 signalling in vivo
Redpath, S. A., Heieis, G. A., & Perona‐Wright, G. (2015) · Cytokine · doi:10.1016/j.cyto.2015.02.026 · Cited by 26
IL-4R alpha deficiency influences hippocampal-BDNF signaling pathway to impair reference memory
Brombacher, T. M., Berkiks, I., Pillay, S., Scibiorek, M., Moses, B., & Brombacher, F. (2020) · Scientific Reports · doi:10.1038/s41598-020-73574-3 · Cited by 26
Stonek, F., Metzenbauer, M., Hafner, E., Philipp, K., & Tempfer, C. M. (2008) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2007.00577.x · Cited by 26
Iribarren, P., Cui, Y.-H., Le, Y., Ying, G., Zhang, X., Gong, W., & Wang, J. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5482 · Cited by 26
“Stimulation of the IL-4R complex by IL-4 results in activation of multiple signaling pathways, one of which involves Stat6.”
BackgroundMethodInfluentialA targeted mutation in the IL-4Rα gene protects mice against autoimmune diabetes
Radu, D. L., Noben-Trauth, N., Hu‐Li, J., Paul, W. E., & Bona, C. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.230431397 · Cited by 25
Serine Phosphorylation of Stat6 Negatively Controls Its DNA-Binding Function
Maiti, N. R., Sharma, P., Harbor, P. C., & Haque, S. J. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.553 · Cited by 27
“(3,21) However, the molecular and cellular events that negatively govern the Stat6-mediated signal transduction and consequent gene activation remain poorly defined.”
Soriano, À., Lozano, F., Oliva, H., García, F., Nomdedéu, M., de Lazzari, E., Rodríguez, C., Barrasa, A., Lorenzo, J. I. L., del Romero, J., et al. (2005) · Immunogenetics · doi:10.1007/s00251-005-0041-x · Cited by 26
“Type II IL-4R is also the receptor of IL-13, another key Th2 cytokine that shares most of the IL-4 functions (Hershey 2003; Nelms et al. 1999 ).”
The immunogenic peptide for Th1 development
Takatsu, K., & Kariyone, A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00209-6 · Cited by 26
Microenvironments‐Modulated Biomaterials Enhance Spinal Cord Injury Therapy
Li, Y., Zhang, Q., Liu, Z., Fu, C., & Ding, J. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202403900 · Cited by 26
Gcanga, L., Tamgue, O., Ozturk, M., Pillay, S., Jacobs, R., Chia, J. E., Mbandi, S. K., Davids, M., Dheda, K. U. J., Schmeier, S., et al. (2022) · Nucleic Acid Therapeutics · doi:10.1089/nat.2022.0009 · Cited by 25
“IL-4 signals through two different receptor complexes, type I receptor (IL-4R a /c g chain) and type II receptor (IL-13R a 1) [52,53].”
IL1α and IL4 signalling in human ovarian surface epithelial cells
Papacleovoulou, G., Critchley, H., Hillier, S. G., & Mason, J. I. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0081 · Cited by 25
Chu, H., Wang, M., Fu, Y., Zhong, D., Shi, D., Ma, L., Pan, X., Qin, C., Yin, C., & Zhang, Z. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr607 · Cited by 25
Liu, W., Yang, Y., Wu, G., & Ignarro, L. J. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00325.2007 · Cited by 25
“The IL-4R- chain cytoplasmic region appears to have three functionally distinct domains, one that acts as an interaction site for the Janus kinase (Jak), one required for activation of proliferation pathways, and a third involved in the activation of pathways leading to induction of gene expression (30).”
BackgroundLiang, J., Liu, Y., Xue, R., Chen, L., Chen, H., Shao, L., Wang, J., & Zhang, X. (2017) · Dermatitis · doi:10.1097/der.0000000000000265 · Cited by 25
Nieuwenhuizen, N. E., Herbert, D. R., Lopata, A. L., & Brombacher, F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2758 · Cited by 25
“subunit is expressed on a wide range of cells (17).”
Background
Metadata
- Authors
- Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., & Paul, W. E.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Nelms, Keats
- Paul, William E.
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 1999-04
- Volume
- 17
- Issue
- 1
- Pages
- 701-738
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W2144120552
- Cited by
- 1,545
- References
- 190
- Citations by year
- 2026: 17 · 2025: 27 · 2024: 52 · 2023: 36 · 2022: 54 · 2021: 43 · 2020: 50 · 2019: 44 · 2018: 54 · 2017: 49 · 2016: 52 · 2015: 56 · 2014: 72 · 2013: 52 · 2012: 55
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- IL-4, IL-4 receptor, common gamma chain, receptor signaling, receptor phosphorylation, cell growth regulation, apoptosis resistance, gene activation, T cell differentiation, cytokine signaling
- MeSH terms
- Amino Acid Sequence, Animals, Humans, Molecular Sequence Data, Phosphoproteins, Signal Transduction, Trans-Activators, Interleukin-4, Protein Tyrosine Phosphatases, Calcium-Calmodulin-Dependent Protein Kinases, Mice, Knockout, Receptors, Interleukin-4, Mitogen-Activated Protein Kinases, Intracellular Signaling Peptides and Proteins, JNK Mitogen-Activated Protein Kinases, STAT6 Transcription Factor, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review